{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:08:06Z","timestamp":1787004486141,"version":"build-2736575974"},"reference-count":44,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,7,1]]},"abstract":"<jats:p>Pre-clinical studies have identified nitroxyl (HNO), the reduced congener of nitric oxide (NO\u2022), as a potent vasodilator which is resistant to tolerance development. The present study explores the efficacy of HNO in human blood vessels and describes, for the first time, a vasodilator for humans that is not susceptible to tolerance. Human radial arteries and saphenous veins were obtained from patients undergoing coronary artery graft surgery and mounted in organ baths. Repeated vasodilator responses to the HNO donor Angeli's salt (AS) and NO\u2022 donor glyceryl trinitrate (GTN) were determined. AS- and GTN-induced concentration-dependent vasorelaxation of both human radial arteries (AS pEC50: 6.5\u00b10.2; \u2212log M) and saphenous veins (pEC50: 6.7\u00b10.1) with similar potency. In human radial arteries, GTN-induced relaxation was reduced by the NO\u2022 scavenger hydroxocobalamin (HXC; P&amp;lt;0.05) but was unaffected by the HNO scavenger L-cysteine. Alternately, AS was unaffected by HXC but was reduced by L-cysteine (5-fold shift, P&amp;lt;0.05). The sGC (soluble guanylate cyclase) inhibitor ODQ abolished responses to both AS and GTN in arteries and veins (P&amp;lt;0.05). Inhibition of voltage-dependent potassium channels (Kv channels) with 4-AP also significantly reduced responses to AS (pEC50: 5.5) and GTN, suggesting that the relaxation to both redox congeners is cGMP- and Kv channel-dependent. Critically, a concentration-dependent development of tolerance to GTN (1 and 10\u00a0\u03bcM; P&amp;lt;0.05), but not to AS, was observed in both saphenous veins and radial arteries. Like GTN, the HNO donor AS causes vasorelaxation of human blood vessels via activation of a cGMP-dependent pathway. Unlike GTN, however, it does not develop tolerance in human blood vessels.<\/jats:p>","DOI":"10.1042\/cs20140759","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T11:54:39Z","timestamp":1425383679000},"page":"179-187","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance"],"prefix":"10.1042","volume":"129","author":[{"given":"Karen\u00a0L.","family":"Andrews","sequence":"first","affiliation":[{"name":"Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie\u00a0G.","family":"Lumsden","sequence":"additional","affiliation":[{"name":"Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Farry","sequence":"additional","affiliation":[{"name":"Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Maree","family":"Jefferis","sequence":"additional","affiliation":[{"name":"Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara\u00a0K.","family":"Kemp-Harper","sequence":"additional","affiliation":[{"name":"Vascular Biology and Immunopharmacology Group, Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaye P.\u00a0F.","family":"Chin-Dusting","sequence":"additional","affiliation":[{"name":"Vascular Pharmacology Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2015,4,24]]},"reference":[{"key":"2021113010400741100_B1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1440-1681.2000.03240.x","article-title":"A short history of nitroglycerine and nitric oxide in pharmacology and physiology","volume":"27","author":"Marsh","year":"2000","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021113010400741100_B2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0140-6736(02)51392-1","article-title":"On the use of nitrate of amyl in angina pectoris","volume":"ii","author":"Brunton","year":"1867","journal-title":"Lancet"},{"key":"2021113010400741100_B3","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.110.981407","article-title":"Nitrate therapy: new aspects concerning molecular action and tolerance","volume":"123","author":"Munzel","year":"2011","journal-title":"Circulation"},{"key":"2021113010400741100_B4","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1089\/ars.2010.3327","article-title":"Nitroxyl (HNO) as a vasoprotective signaling molecule","volume":"14","author":"Bullen","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"2021113010400741100_B5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.tips.2008.08.005","article-title":"Nitroxyl (HNO): the Cinderella of the nitric oxide story","volume":"29","author":"Irvine","year":"2008","journal-title":"Trends Pharmcol. Sci."},{"key":"2021113010400741100_B6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1476-5381.2009.00150.x","article-title":"A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries","volume":"157","author":"Andrews","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"2021113010400741100_B7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/sj.bjp.0703058","article-title":"Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta","volume":"129","author":"Ellis","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"2021113010400741100_B8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cardiores.2006.11.018","article-title":"The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature","volume":"73","author":"Favaloro","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"2021113010400741100_B9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1021\/tx0496800","article-title":"The physiological chemistry and biological activity of nitroxyl (HNO): the neglected, misunderstood, and enigmatic nitrogen oxide","volume":"18","author":"Fukuto","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"2021113010400741100_B10","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/01.HYP.0000072010.54901.DE","article-title":"NO\u2212 activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries","volume":"41","author":"Irvine","year":"2003","journal-title":"Hypertension"},{"key":"2021113010400741100_B11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.bjp.0704269","article-title":"Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion","volume":"134","author":"Wanstall","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"2021113010400741100_B12","doi-asserted-by":"publisher","first-page":"10463","DOI":"10.1073\/pnas.181191198","article-title":"Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in\u00a0vivo by calcitonin gene-related peptide signaling","volume":"98","author":"Paolocci","year":"2001","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"2021113010400741100_B13","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1089\/ars.2010.3269","article-title":"Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA\/NO","volume":"14","author":"Irvine","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"2021113010400741100_B14","doi-asserted-by":"publisher","first-page":"H939","DOI":"10.1152\/ajpheart.00630.2012","article-title":"Nitroxyl donors retain their depressor effects in hypertension","volume":"305","author":"Irvine","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113010400741100_B15","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1073\/pnas.0937302100","article-title":"Positive inotropic and lusitropic effects of HNO\/NO\u2212 in failing hearts: independence from \u03b2-adrenergic signaling","volume":"100","author":"Paolocci","year":"2003","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"2021113010400741100_B16","doi-asserted-by":"publisher","first-page":"H1274","DOI":"10.1152\/ajpheart.00008.2009","article-title":"Redox variants of NO (NO\u2022 and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms","volume":"296","author":"Favaloro","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113010400741100_B17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s002100100453","article-title":"Involvement of cyclic GMP and potassium channels in relaxation evoked by the nitric oxide donor, diethylamine NONOate, in the rat small isolated mesenteric artery","volume":"364","author":"Sampson","year":"2001","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"2021113010400741100_B18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/01.HYP.0000259328.04159.90","article-title":"Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae","volume":"49","author":"Irvine","year":"2007","journal-title":"Hypertension"},{"key":"2021113010400741100_B19","doi-asserted-by":"publisher","first-page":"H1405","DOI":"10.1152\/ajpheart.00489.2011","article-title":"Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia","volume":"301","author":"Bullen","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113010400741100_B20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1124\/jpet.112.199836","article-title":"Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects","volume":"344","author":"Donzelli","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021113010400741100_B21","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1161\/CIRCHEARTFAILURE.113.000632","article-title":"Nitroxyl (HNO): a novel approach for the acute treatment of heart failure","volume":"6","author":"Sabbah","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"2021113010400741100_B22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.CCM.0000292155.06797.62","article-title":"Effects of aspirin, nimesulide, and SC-560 on vasopressin-induced contraction of human gastroepiploic artery and saphenous vein","volume":"36","author":"Aldasoro","year":"2008","journal-title":"Crit. Care. Med."},{"key":"2021113010400741100_B23","doi-asserted-by":"crossref","first-page":"H2451","DOI":"10.1152\/ajpheart.2001.280.6.H2451","article-title":"Is hydrogen peroxide an EDHF in human radial arteries?","volume":"280","author":"Hamilton","year":"2001","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"2021113010400741100_B24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1476-5381.1988.tb16568.x","article-title":"Autoradiographic localization and function of beta-adrenoceptors on the human internal mammary artery and saphenous vein","volume":"95","author":"Molenaar","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"2021113010400741100_B25","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/sj.bjp.0703700","article-title":"S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery","volume":"131","author":"Sogo","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"2021113010400741100_B26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1067\/mtc.2000.109000","article-title":"Tetrahydrobiopterin improves endothelial function in human saphenous veins","volume":"120","author":"Verma","year":"2000","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"2021113010400741100_B27","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/sj.bjp.0702622","article-title":"Role of superoxide dismutase in in\u00a0vivo and in\u00a0vitro nitrate tolerance","volume":"127","author":"Munzel","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"2021113010400741100_B28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00005344-198707000-00012","article-title":"Effects of glyceryl trinitrate on endothelium-dependent and -independent relaxation and cyclic GMP levels in rat aorta and human coronary artery","volume":"10","author":"Rapoport","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2021113010400741100_B29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0022-3565(25)09496-0","article-title":"Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery","volume":"273","author":"MacAllister","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021113010400741100_B30","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/hc1002.105186","article-title":"Functional and biochemical analysis of endothelial (dys)function and NO\/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment","volume":"105","author":"Schulz","year":"2002","journal-title":"Circulation"},{"key":"2021113010400741100_B31","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1124\/mol.104.002600","article-title":"Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates","volume":"66","author":"Daiber","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"2021113010400741100_B32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1440-1681.1993.tb01645.x","article-title":"Effects of hydroxocobalamin and haemoglobin on no-mediated relaxations in the rat anococcygeus muscle","volume":"20","author":"Li","year":"1993","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021113010400741100_B33","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00424-007-0249-8","article-title":"cGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin- and nitric-oxide-induced relaxation in porcine coronary artery","volume":"454","author":"Qin","year":"2007","journal-title":"Pflugers Arch."},{"key":"2021113010400741100_B34","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/0006-2952(96)00078-0","article-title":"Nitric oxide (NO), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase","volume":"51","author":"Dierks","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"2021113010400741100_B35","doi-asserted-by":"publisher","first-page":"21788","DOI":"10.1074\/jbc.M109.014282","article-title":"The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols","volume":"284","author":"Miller","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2021113010400741100_B36","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1124\/mol.109.059915","article-title":"Mechanisms underlying activation of soluble guanylate cyclase by the HNO donor Angeli's salt","volume":"5","author":"Zeller","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"2021113010400741100_B37","doi-asserted-by":"publisher","first-page":"9196","DOI":"10.1073\/pnas.1430507100","article-title":"A biochemical rationale for the discrete behaviour of nitroxyl and nitric oxide in the cardiovascular system","volume":"100","author":"Miranda","year":"2003","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"2021113010400741100_B38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.placenta.2004.12.013","article-title":"Nitric oxide donors mediate vasodilation in human placental arteries partly through a direct effect on potassium channels","volume":"27","author":"Sand","year":"2006","journal-title":"Placenta"},{"key":"2021113010400741100_B39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1042\/CS19980338","article-title":"Does potassium channel opening contribute to endothelium-dependent relaxation in human internal thoracic artery?","volume":"96","author":"Hamilton","year":"1999","journal-title":"Clin. Sci."},{"key":"2021113010400741100_B40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cardiores.2006.04.002","article-title":"Membrane potassium currents in human radial artery and their regulation by nitric oxide donor","volume":"71","author":"Zhang","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"2021113010400741100_B41","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/0735-1097(89)90216-7","article-title":"Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina","volume":"13","author":"DeMots","year":"1989","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010400741100_B42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/oxfordjournals.eurheartj.a059425","article-title":"Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule","volume":"10","author":"Ferratini","year":"1989","journal-title":"Eur. Heart J."},{"key":"2021113010400741100_B43","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/j.jacc.2007.08.031","article-title":"Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels","volume":"50","author":"Hink","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010400741100_B44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2261-6-44","article-title":"Mitochondrial oxidative stress and nitrate tolerance\u2013comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+\/- mice","volume":"6","author":"Mollnau","year":"2006","journal-title":"BMC Cardiovasc. Disord."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/129\/2\/179\/443942\/cs1290179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/129\/2\/179\/443942\/cs1290179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T13:38:09Z","timestamp":1747748289000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/129\/2\/179\/71310\/Nitroxyl-a-vasodilator-of-human-vessels-that-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,24]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,7,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20140759","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,24]]}}}